3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
14
Burkitt Lymphoma
10
Neoplasms
7
Lymphoma, Follicular
7
Hodgkin Disease
6
Triple Negative Breast Neoplasms
5
Sarcoma
5
Ovarian Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Endometrial Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, B-Cell
4
Breast Neoplasms
4
Wilms Tumor
3
Sarcoma, Ewing
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Osteosarcoma
3
Lymphoma, Mantle-Cell
3
Liposarcoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Fallopian Tube Neoplasms
3
Plasmablastic Lymphoma
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Leiomyosarcoma
2
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
enasidenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esthesioneuroblastoma, Olfactory
×
Doxorubicin
×
30 days
×
Clear all
No trials found.